It is now recognized as an anaplastic kinase-negative (ALK-), CD30 + lymphoma, a distinct T-cell–derived lymphoma within the non-Hodgkin’s lymphoma spectrum [5]. This evidence concerns the gene TNFRSF8 and lymphoma.